Hope helped me navigate my testicular cancer diagnosis at 20 ... CLDN6-positive advanced solid tumors, including platinum-resistant ovarian cancer.

Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant. | Following a ...

Recently published survey results indicate that more needs to be done to educate US adults about testicular cancer, ...

The decision comes as the company is discontinuing clinical testing of a CLDN6-targeted CAR T-cell therapy in testicular cancer.

and couldn't be detected if a mouse had a mammary tumor instead of a malignant testicular cancer, or if a testicular tumor was benign. This specificity makes these miRNAs very accurate biomarkers.

Testicular cancer develops when abnormal cells begin to grow uncontrollably in one or both testicles, eventually forming a tumor. This often-painless lump or swelling can vary in size from as ...

Cornell researchers have confirmed that a previously identified biomarker for detecting the presence of malignant testicular germ cell tumors – the most common solid cancers in young men – has the ...